Brind.

Leerink Partners cut price target on Stryker Corporation, and Norges Bank bought a new position in Stryker shares.

1 report, 1 independent Updated Aug 15

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Stryker Corporation Leerink partners Norges Bank

Keep exploring

The entities involved

Stryker Corporation
American medical technologies company
- MarketBeat's stock screener tool highlights Glaukos, Boston Scientific, and Stryker Corporation as medical stocks to watch.Sun 14:42
- Major combat vehicle contractors, including General Dynamics and Ajax, are producing vehicles such as Stryker and SGT Stout.Thu 00:51
Leerink partners
U.S. investment bank
- Leerink Partners reduced its target price for Keros Therapeutics on November 2, 2026.11:50
- Leerink Partners decreased its target price on CVS Health, while BNP Paribas and Wyoming increased their holdings.Sun 10:56
Norges Bank
central bank of Norway
- Norges Bank monitors unemployment data from the Norwegian Labour and Welfare Administration, and both Norges Bank and Danske Bank influence krone valuation.10:51
- Merck KGaA stock saw activity as an EVP sold shares, while Mirae Asset increased its stake, alongside Norges Bank's previous acquisition.Sun 13:04

Coverage

Newest first; wire copies grouped

Aug 15themarketsdaily.com